Metraipolis › archive › dc_87ed9fa3beae

Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions — Europe PMC PMID:41106780

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41106780
DOI
10.1016/j.virusres.2025.199642
License (as archived)
solo-consultazione
Archived
2026-11-09T07:08:19.832Z
SHA-256 of the archived text
3ff92ef4e94fbaf870500d80bd363b21606a8aa06abbf10ce185ae60640dd3a0
Stable URL of this page
https://metraipolis.com/documento/dc_87ed9fa3beae

How to cite

Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions — Europe PMC PMID:41106780 — Europe PMC (en), https://europepmc.org/article/MED/41106780 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_87ed9fa3beae (Metraipolis archive dc_87ed9fa3beae, sha256 3ff92ef4e94fbaf870500d80bd363b21606a8aa06abbf10ce185ae60640dd3a0)
BibTeX
@misc{dc87ed9fa3beae,
  title = {Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions — Europe PMC PMID:41106780},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41106780},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_87ed9fa3beae; sha256 3ff92ef4e94fbaf870500d80bd363b21606a8aa06abbf10ce185ae60640dd3a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41106780. Agents can read the archived copy with the MCP tool read_document.